More COVID-19 Vaccines To Be Approved In Coming Months: Dr Harsh Vardhan
More COVID-19 Vaccines To Be Approved In India In Next Few Months: Health Minister Dr Harsh VardhanHealth Minister Dr Harsh Vardhan (Facebook/@drharshvardhanofficial)

In a big fillip to the nation's fight against the COVID-19 pandemic, Union Health Minister Dr Harsh Vardhan yesterday (15 February) said that India may approve more vaccine candidates for emergency use in the next few months, reports Hindustan Times.

Dr Vardhan highlighted that there are 18-19 COVID-19 vaccines in various stages of development in the nation.

The Health Minister however also added that it would not be appropriate for him to say which vaccine will get emergency use approval and how much time it would take as the said approval is not given by either him or the other officials who were sharing the dais with him during the press conference.

Dr Vardhan also added that the sale of COVID-19 vaccines may not be allowed in the open markets as long as they only have an emergency use authorisation. As of now, no private sales of vaccines are allowed in India.

“The research for other Covid-19 vaccine candidates is already there. Department of biotechnology has been given specifically ₹900 crore to help such candidates, who have a potential...,” the Health Minister was quoted as saying.

As of now, only two vaccines have been accorded emergency use authorisation in India, Covishield and Covaxin.

The Covishield has developed by pharmaceutical major AstraZeneca and University of Oxford and is being manufactured by Pune based Serum Institute of India.

Meanwhile, Covaxin has been indigenously developed by Hyderabad based Bharat Biotech in close collaboration with Pune based National Institute of Virology and the Indian Council for Medical Research.

An Appeal...

Dear Reader,

As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.

Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.

We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.

Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.

Become A Patron
Become A Subscriber